Exploratory Platform Research on Precision Therapy of Advanced Pancreatic Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Pancreatic Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (XianJun Yu, M.D., Ph.D.) · yuxianjun@fudanpci.org · +86-21-6417-5590
Contact: Principal Investigator (Xianjun Yu, M.D., Ph.D.)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer

Metastatic Colorectal Cancer · Metastatic Pancreatic Cancer · Metastatic Ovarian Cancer

Abroad (travel likely)RecruitingPHASE2

Bethesda, United States

Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma

Metastatic Pancreatic Ductal Adenocarcinoma · Stage IV Pancreatic Cancer AJCC v8

Abroad (travel likely)RecruitingPHASE1, PHASE2

Buffalo, United States

A Phase Ib/II Clinical Study of Regorafenib Combined With Toripalimab and Albumin-bound Paclitaxel for the Third-line Treatment of Advanced Pancreatic Cancer

Pancreatic Cancer Metastatic

Abroad (travel likely)RecruitingPHASE1, PHASE2

Shenzhen, China

A Phase II Study of HRS-4642 Combined With AG (Nab-paclitaxel and Gemcitabine) as Conversion Therapy for Locally Advanced Pancreatic Cancer

Locally Advanced Pancreatic Cancer With KRAS G12D Mutation

Abroad (travel likely)RecruitingPHASE2

Nanjing, China